Robotic-Assisted pelvic lymph node dissection

Radical cystectomy with pelvic lymphadenectomy represents the gold standard for treatment of muscle-invasive bladder cancer. The extent of the lymph node (LN) dissection and LN involvement during radical cystectomy is the powerful prognostic factors associated with poor oncological outcome. However, the optimal boundaries of the LN dissection during a radical cystectomy (RC) are controversial. During the last decade, urologists worldwide have witnessed a development of laparoscopic surgical treatment due to the development of robot-assisted surgery in many urological diseases. In parallel the interest in expanding the role of robot-assisted radical cystectomy (RARC) for the management of urinary bladder cancer has increased, and more urologists have started to perform pelvic lymph node dissection (PLND) robotically.